Team
Portfolio
Value Proposition
Careers
Newsroom
Contact
LP Login
Active Portfolio
Supira
Participated in Supira’s $35m Series B financing in February 2020
R3 Vascular
Co-Led R3’s $17.8m Series A financing in September 2020
Moray Medical
Led Moray’s $5.7m Seed financing in January 2021
CorFlow Therapeutics
INVESTOR SINCE MARCH 2021
Cardiac Success
LED CARDIAC SUCCESS' $5.2M SERIES A financing IN JUNE 2021
Aktiia
PARTICIPATED IN AKTIIA’S $17.5M SERIES A FINANCING IN SEPTEMBER 2021
Distalmotion
Participated in Distalmotion’s $90M Series E Financing in December 2021
TriCares
Led TriCares’ €47M Series C Financing Round in September 2022
Legacy Portfolio Exits
Vesper Medical
Sold to Royal Philips (NYSE: PHG) in 2021
CoRRect Medical
Sold to Uniphar PLC (LON:UPR) in 2021
Intact Vascular
SOLD TO ROYAL PHILIPS (NYSE: PHG) IN 2020
Rebound Therapeutics
Sold to Integra LifeSciences (NASDAQ: IART) in 2019
Claret Medical
Sold to Boston Scientific (NYSE: BSX) in 2018
Essential Medical
Sold to Teleflex (NYSE: TFX) in 2018
ImThera Medical
Sold to LivaNova (NASDAQ: LIVN) in 2018
ReCor Medical
Sold to Otsuka Holdings (TYO: 4578) in 2018
Regis Medical
Exited in 2018
Boston Heart Diagnostics
Sold to Eurofins Scientific (Euronext: ERF) in 2015
CardiAQ Valve Technologies
Sold to Edwards LifeSciences (NYSE: EW) in 2015
Loma Vista Medical
Sold to C.R. Bard (NYSE: BCR) in 2013, now part of Becton Dickinson (NYSE: BDX)
Atritech
Sold to Boston Scientific (NYSE: BSX) in 2011
Embrella Cardiovascular
Sold to Edwards LifeSciences (NYSE: EW) in 2011
CoreValve
Sold to Medtronic (NYSE: MDT) in 2009
Ovum Ventures
Sold to Medtronic (NYSE: MDT) in 2009
ArteriA
Sold to W.L. Gore in 2005
Micrus Endovascular
IPO (NASDAQ: MEND) in 2005
ACIST
Sold to Bracco Group in 2001
Cardiologic
Sold to Boston Scientific (NYSE: BSX) in 2001
Embolic Protection
Sold to Boston Scientific (NYSE: BSX) in 2001
Vascular Solutions
IPO (NASDAQ: VASC) in 2001, now part of Teleflex (NYSE: TFX)
Endologix
IPO (NASDAQ: ELGX) in 2000
Vascular Science
Sold to St. Jude Medical (NYSE: STJ) in 1999, now part of Abbott Laboratories (NYSE: ABT)
